3 hasil untuk "Alexander C. Angleitner"
Menampilkan 1–3 · 0,27 detik · RSS
-
Artikel Jurnal
Δ-β2M as a dynamic biomarker for predicting ICU admission after CAR T-cell therapy
Abstract CAR T-cell therapy is associated with life-threatening toxicities requiring intensive care unit (ICU) admission. Reliable biomarkers for early risk stratification are lacking. We evaluated Δ-β2-microglobulin (Δ-β2M) as a dynamic biomarker for predicting ICU admission after CAR T-cell…
-
Artikel Jurnal
Matched comparison of therapeutic DLI and second allogeneic transplantation after relapse of acute leukemia or MDS
BackgroundRelapse is the main cause of treatment failure after allogeneic hematopoietic cell transplantation (allo-HCT). Therapeutic donor lymphocyte infusion (DLI) and second allo-HCT are common post-relapse options, but comparative evidence from the time of relapse is limited.MethodsWe…
-
Artikel Jurnal
Timing of donor lymphocyte infusion after relapse following allogeneic hematopoietic cell transplantation: a retrospective single-center analysis
Abstract Donor lymphocyte infusions (DLI) are an important strategy for managing relapse after allogeneic hematopoietic stem cell transplantation (allo-HCT), yet data on the impact of surveillance frequency and DLI timing remain limited. We retrospectively analyzed 83 adults with acute leukemia or…